Importance of platelets and platelet response in acute coronary syndromes

Area of Science:

• Cardiovascular Medicine
• Hematology
• Thrombosis Research

Background:

• Platelet activation is crucial in atherothrombosis development and progression.
• Elevated platelet count, activation, and hyperreactivity are linked to adverse cardiovascular events in acute coronary syndromes.
• Platelet hyperreactivity signifies residual platelet activity despite antiplatelet drug therapy.

Purpose of the Study:

• To review current understanding of platelet function assays in assessing antiplatelet therapy effectiveness.
• To discuss the challenges in defining optimal assays for residual platelet activity and their predictive values.
• To highlight the need for standardized protocols in platelet function testing.

Main Methods:

• Review of accumulating clinical evidence and existing literature on platelet function assays.
• Analysis of various assays measuring platelet activation and aggregation.
• Discussion of specific applications of different testing methods, including P2Y(12) receptor inhibition.

Main Results:

• Platelet aggregation is the current gold standard for platelet function testing.
• Alternative assays show promise for detecting overall platelet hyperreactivity and P2Y(12) inhibition.
• The optimal assays for measuring residual platelet activity and their predictive values require further definition.

Conclusions:

• Standardized testing protocols for platelet aggregation are essential for study consistency.
• Further research is necessary to establish reliable assays for residual platelet activity in patients on antiplatelet therapy.
• Accurate assessment of platelet function is critical for managing atherothrombosis risk in cardiovascular patients.